z-logo
open-access-imgOpen Access
Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women
Author(s) -
Jing Tao,
Xin Shen,
Jie Li,
Erdenbat Cha,
Pei-Pei Gu,
Jun Li,
Wei Zhu,
Lin-Long He,
Guoqing Li,
Weigang Zhao
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000019959
Subject(s) - medicine , metabolic syndrome , creatinine , uric acid , endocrinology , body mass index , blood pressure , confounding , waist , high density lipoprotein , diabetes mellitus , cholesterol , gastroenterology , obesity
This study aimed to investigate the association between Serum Uric Acid (UA) to Creatinine (Cr) Ratio (UA/Cr) and metabolic syndrome (MetS) in postmenopausal women. A total of 455 patients with MetS and 457 age- and gender- matched controls were included in the present retrospective study. Serum levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting plasma glucose (FPG), Cr, and UA were measured. We employed logistic regression analysis to investigate the association between serum UA/Cr and MetS in postmenopausal women. Serum UA/Cr levels were significantly higher in patients with MetS than that in control subjects ( P < .05). In the correlation analysis, serum UA/Cr showed a significantly positive correlation with age, hypertension, systolic pressure (SBP), diastolic pressure (DBP), Waist, body mass index (BMI), TG, UA and negative correlation with type 2 diabetes mellitus (T2DM) and Cr ( P all < .001). Moreover, multivariate analysis revealed that serum UA/Cr was still an independent risk factor for MetS (OR = 2.928, 95% CI = 2.385–3.596, P < .001) after adjustments for other confounders. Serum UA/Cr are strongly associated with the risk of MetS in postmenopausal Chinese women.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here